Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Cytokinetics (CYTK) Other Gross PP&E Adjustments (2016 - 2025)

Cytokinetics (CYTK) has disclosed Other Gross PP&E Adjustments for 15 consecutive years, with $50.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments changed N/A to $50.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $50.5 million, a N/A change, with the full-year FY2025 number at $50.5 million, changed N/A from a year prior.
  • Other Gross PP&E Adjustments was $50.5 million for Q4 2025 at Cytokinetics, up from -$77.6 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $50.5 million in Q4 2025 to a low of -$83.0 million in Q2 2021.
  • A 5-year average of -$56.2 million and a median of -$77.2 million in 2024 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: tumbled 53.45% in 2021, then increased 22.28% in 2023.
  • Cytokinetics' Other Gross PP&E Adjustments stood at $16.3 million in 2021, then dropped by 9.26% to $14.8 million in 2022, then grew by 22.28% to $18.1 million in 2023, then plummeted by 521.58% to -$76.3 million in 2024, then soared by 166.17% to $50.5 million in 2025.
  • Per Business Quant, the three most recent readings for CYTK's Other Gross PP&E Adjustments are $50.5 million (Q4 2025), -$77.6 million (Q3 2025), and -$76.1 million (Q2 2025).